Search

Author/Creator Buonamici, S.

1. 21 SF3B1 MUTATIONS INDUCE ABERRANT SPLICING LEADING TO A BLOCK IN ERYTHROID DIFFERENTIATION AND COMPETITIVE ADVANTAGE. (April 2015)

Authors:
Buonamici, S.; Perino, S.; Lim, K.; Darman, R.; Feala, J.; Peng, S.; Bhavsar, E.; Corson, L.; Keaney, G.; Mizui, Y.; Obeng, E.; Park, E.; Wang, J.; Warmuth, M.; Yu, L.; Zhu, P.; Furman, R.; Ebert, B.; Smith, P.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S9
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterization of Novel Oral Splicing Modulator, H3B-8800, Identifies the Mechanistic Basis for its Preferential Lethality Towards Spliceosome-Mutant Myeloid Malignancy Models. (April 2017)

Authors:
Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Csibi, A.; Fekkes, P.; Klimek, V.; Kumar, P.; Lee, S.C.W.; Padron, E.; Pazolli, E.; Goldberg, J.; Sahmoud, T.; Taylor, J.; Warmuth, M.; Yu, L.; Zhu, P.; Abdel-Wahab, O.; Smith, P.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search